Cargando…

On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry

BACKGROUND. Dialysis bath production, at least in Europe, is currently based on pre-produced aqueous solutions of dialysis salts (concentrate), which are re-handled by dialysis machines to deliver the final dialysate concentrations. Because of the logistics of aqueous solution creation, a large amou...

Descripción completa

Detalles Bibliográficos
Autores principales: Beige, Joachim, Lutter, Steffen, Martus, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401082/
https://www.ncbi.nlm.nih.gov/pubmed/22833811
http://dx.doi.org/10.1093/ckj/sfs043
_version_ 1782238563287433216
author Beige, Joachim
Lutter, Steffen
Martus, Peter
author_facet Beige, Joachim
Lutter, Steffen
Martus, Peter
author_sort Beige, Joachim
collection PubMed
description BACKGROUND. Dialysis bath production, at least in Europe, is currently based on pre-produced aqueous solutions of dialysis salts (concentrate), which are re-handled by dialysis machines to deliver the final dialysate concentrations. Because of the logistics of aqueous solution creation, a large amount of transportation capacity is needed. Therefore, we changed this process to use pre-produced dry salt containers and to undertake in-clinic dissolution of salts and concentration production. Because no preclinical control for solute concentrations is available so far using this new process, we employed routine clinical chemistry analytics. METHODS. We report the controls of solute concentrations created by these methods for 746 samples of concentrates and 151 dissolution processes. For analysis, absolute and relative deviations from prescriptions and associations between the solute concentrations and the density controls of the concentrates were computed. RESULTS. A total of 98% of all the concentrates were found to be within a 10% margin of error from the prescriptions. The mean relative deviation of the solute concentrations from the prescriptions was −0.635 ± 3.83%. Among particular solutes, sodium had the highest maximum deviation of 26 mmol/L from the prescription. Calcium and magnesium (small concentration solutes) exhibited small systematic errors of 1.37 and 1.22%, respectively. Other solute concentrations showed random errors only and no associations with the mean relative deviations of all the solutes within a production batch or with the density controls. CONCLUSIONS. Single solute concentration control by routine clinical chemistry after dry salt production of concentrates is a valuable additional tool for monitoring clinical risk with dialysate concentrates. The analytical random error of clinical chemistry exceeds the weight tolerance of production; therefore, such analytics cannot be used for precision production and control of dry salt containers.
format Online
Article
Text
id pubmed-3401082
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-34010822012-08-28 On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry Beige, Joachim Lutter, Steffen Martus, Peter Clin Kidney J Original Contributions BACKGROUND. Dialysis bath production, at least in Europe, is currently based on pre-produced aqueous solutions of dialysis salts (concentrate), which are re-handled by dialysis machines to deliver the final dialysate concentrations. Because of the logistics of aqueous solution creation, a large amount of transportation capacity is needed. Therefore, we changed this process to use pre-produced dry salt containers and to undertake in-clinic dissolution of salts and concentration production. Because no preclinical control for solute concentrations is available so far using this new process, we employed routine clinical chemistry analytics. METHODS. We report the controls of solute concentrations created by these methods for 746 samples of concentrates and 151 dissolution processes. For analysis, absolute and relative deviations from prescriptions and associations between the solute concentrations and the density controls of the concentrates were computed. RESULTS. A total of 98% of all the concentrates were found to be within a 10% margin of error from the prescriptions. The mean relative deviation of the solute concentrations from the prescriptions was −0.635 ± 3.83%. Among particular solutes, sodium had the highest maximum deviation of 26 mmol/L from the prescription. Calcium and magnesium (small concentration solutes) exhibited small systematic errors of 1.37 and 1.22%, respectively. Other solute concentrations showed random errors only and no associations with the mean relative deviations of all the solutes within a production batch or with the density controls. CONCLUSIONS. Single solute concentration control by routine clinical chemistry after dry salt production of concentrates is a valuable additional tool for monitoring clinical risk with dialysate concentrates. The analytical random error of clinical chemistry exceeds the weight tolerance of production; therefore, such analytics cannot be used for precision production and control of dry salt containers. Oxford University Press 2012-06 /pmc/articles/PMC3401082/ /pubmed/22833811 http://dx.doi.org/10.1093/ckj/sfs043 Text en © The Author 2012. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Contributions
Beige, Joachim
Lutter, Steffen
Martus, Peter
On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
title On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
title_full On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
title_fullStr On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
title_full_unstemmed On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
title_short On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
title_sort on-site production of a dialysis bath from dry salts. results of solute concentration control by routine clinical chemistry
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401082/
https://www.ncbi.nlm.nih.gov/pubmed/22833811
http://dx.doi.org/10.1093/ckj/sfs043
work_keys_str_mv AT beigejoachim onsiteproductionofadialysisbathfromdrysaltsresultsofsoluteconcentrationcontrolbyroutineclinicalchemistry
AT luttersteffen onsiteproductionofadialysisbathfromdrysaltsresultsofsoluteconcentrationcontrolbyroutineclinicalchemistry
AT martuspeter onsiteproductionofadialysisbathfromdrysaltsresultsofsoluteconcentrationcontrolbyroutineclinicalchemistry